Forteo is used for treating men and postmenopausal women with osteoporosis who are at high risk for fractures. The drug is not approved for use in children. Healthcare providers may also occasionally recommend off-label Forteo uses, such as for the treatment of osteoporosis due to steroid use, low levels of parathyroid hormone, and osteoporosis in premenopausal women.
Forteo™ (teriparatide) is a prescription medication that is approved for the treatment of osteoporosis. It is a manufactured version of parathyroid hormone and must be given by injection. Specifically Forteo is approved for use in the following groups of people:
- Postmenopausal women with osteoporosis and a high risk for a fracture
- Men with primary osteoporosis (that is not due to other medical conditions or medications) or hypogonadal osteoporosis (which is caused by low levels of testosterone) and a high risk for a fracture
- Men or women with osteoporosis due to long-term use of glucocorticoid steroids (such as prednisone) and a high risk for a fracture.
If you have osteoporosis, you may be at high risk for fractures if:
- You have already had a fracture due to osteoporosis
- You cannot take other osteoporosis medications (or they have not been effective for you)
- Your healthcare provider thinks you are at high risk for fractures.